Ala. Admin. Code r. 420-10-1-.01

Current through Register Vol. 42, No. 10, July 31, 2024

Section 420-10-1-.01 - Purpose

The purpose of these rules is to provide administrative details and procedures for the care and treatment of newborns identified with phenylketonuria, hypothyroidism, galactosemia, congenital adrenal hyperplasia, hearing loss, hemoglobinopathy, biotinidase deficiency, cystic fibrosis, aminoacidopathies, fatty acid oxidation disorders, organic acidurias and acidemias, critical congenital heart disease, severe combined immunodeficiency, spinal muscular atrophy, x-linked adrenoleukodystrophy, lysosomal storage disorders, and other heritable diseases.

Filed December 21, 1987. Amended: Filed September 18, 2002; effective October 23, 2002. Repealed and New Rule: Filed December 17, 2003; effective January 21, 2004. Amended: Filed December 17, 2007; effective January 21, 2008. Amended: Filed May 17, 2013; effective June 21, 2013.

Amended by Alabama Administrative Monthly Volume XXXV, Issue No. 04, January 31, 2017, eff. 3/5/2017.

Amended by Alabama Administrative Monthly Volume XL, Issue No. 03, December 30, 2021, eff. 2/13/2022.

Authors: P. Scott Harris, M.D., Thomas M. Miller, M.D., Lucinda G. Ashley, R.N. - B.C., Rachael N. Montgomery, B.S.N., R.N.

Statutory Authority:Code of Ala. 1975, §§ 22-2-2, 22-20-3.